Pinderfields Hospital is an acute District General Hospital in Wakefield, West Yorkshire operated by the Mid Yorkshire Hospitals NHS Trust.

During the past decade, Pinderfields General Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 3 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pinderfields General Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "University of Edinburgh" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Lymphoma Trials Office" with 2 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pinderfields General Hospital" #1 collaborator was "Cancer Research UK" with 5 trials as a collaborator, "NHS Lothian" with 3 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Takeda" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Pinderfields General Hospital" are "Lymphoma" (6 trials), "Multiple Myeloma" (4 trials), "Coronary Artery Disease" (3 trials), "Prostate Cancer" (3 trials) and "Plaque Psoriasis" (2 trials). Many other conditions were trialed in "Pinderfields General Hospital" in a lesser frequency.

Most popular intervention types in "Pinderfields General Hospital" are "Drug" (26 trials), "Procedure" (12 trials), "Other" (11 trials), "Biological" (8 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "Cyclophosphamide" (3 trials), "Fludarabine" (3 trials), "Placebo" (3 trials) and "etoposide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Pinderfields General Hospital" are 41 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Pinderfields General Hospital". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Pinderfields General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pinderfields General Hospital, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".